(including those on complement inhibitor treatment i.e. eculizumab) should be vaccinated in accordance with the recommended schedules in and of Green (see MenB Risk Groups ‘The Book’ PGD). Individuals requiring vaccination for occupational health reasons, eg laboratory workers working with meningococci, should be referred to their occupational health service provider for vaccination. Individuals who have a history of anaphylactic allergy to latex should not be administered 4CMenB unless the benefit of vaccination outweighs the risk of an allergic reaction A PSD will be required. – Individuals suffering acute severe febrile illness should postpone immunisation until they have recovered; immunisers should advise when the individual can be vaccinated and ensure another appointment is arranged. Seek appropriate advice from the local Screening and Immunisation Team, local Health Protection Team or the as individual’s clinician required. The risk to the individual of not being immunised must be taken into account. Document the reason for exclusion and any action taken in the clinical records. individual’s In a GP practice setting, inform or refer to the GP or a prescriber as appropriate. Informed consent, from the individual or a person legally able to act on the must be obtained for each administration. Action to be taken if the person’s behalf, patient or carer declines Advise the individual/parent/carer about the protective effects of the treatment vaccine, the risks of infection and potential complications of disease. Document advice given and the decision reached. In a GP practice setting, inform or refer to the GP as appropriate. Arrangements for referral As per local policy for medical advice Description of treatment Name, strength & Meningococcal group B Vaccine (rDNA, component, adsorbed), formulation of drug 4CMenB, eg: Bexsero® suspension for injection, 0.5ml, in a pre-filled syringe Legal category Prescription only medicine (POM) Black triangle No Off-label use The vaccine schedule differs from the current Bexsero® SPC. However, the national routine schedule is as recommended by the Joint Committee of Vaccination and Immunisation (JCVI) and Public Health England, in line with of Green and the vaccine ‘The Book’
(including those on complement inhibitor treatment i.e. eculizumab) should be vaccinated in accordance with the recommended schedules in and of ‘The Green Book’ (see MenB Risk Groups PGD). Individuals requiring vaccination for occupational health reasons, eg laboratory workers working with meningococci, should be referred to their occupational health service provider for vaccination. Individuals who have a history of anaphylactic allergy to latex should not be administered 4CMenB unless the benefit of vaccination outweighs the risk of an allergic reaction – A PSD will be required. Individuals suffering acute severe febrile illness should postpone immunisation until they have recovered; immunisers should advise when the individual can be vaccinated and ensure another appointment is arranged. Seek appropriate advice from the local Screening and Immunisation Team, local Health Protection Team or the individual’s clinician as required. The risk to the individual of not being immunised must be taken into account. Document the reason for exclusion and any action taken in the individual’s clinical records. In a GP practice setting, inform or refer to the GP or a prescriber as appropriate. Action to be taken if the patient or carer declines treatment Informed consent, from the individual or a person legally able to act on the person’s behalf, must be obtained for each administration. Advise the individual/parent/carer about the protective effects of the vaccine, the risks of infection and potential complications of disease. Document advice given and the decision reached. In a GP practice setting, inform or refer to the GP as appropriate. Arrangements for referral for medical advice As per local policy Description of treatment Name, strength & formulation of drug Meningococcal group B Vaccine (rDNA, component, adsorbed), 4CMenB, eg: Bexsero® suspension for injection, 0.5ml, in a pre-filled syringe Legal category Prescription only medicine (POM) Black triangle No Off-label use The vaccine schedule differs from the current Bexsero® SPC. However, the national routine schedule is as recommended by the Joint Committee of Vaccination and Immunisation (JCVI) and Public Health England, in line with of ‘The Green Book’ and the vaccine